HONG KONG, SHANGHAI and FLORHAM PARK, N.J., May 17, 2024 HUTCHMED Limited today announces that topline and subgroup results from the ESLIM-01 Phase III study of sovleplenib, as well as new.
SUZHOU, China and ROCKVILLE, Md., May 15, 2024 /PRNewswire/ Ascentage Pharma , a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B , and.
EHA 2024 Results From Five Studies Of Ascentage Pharma's Key Drug Candidates Selected For Presentations At 2024 European Hematology Association Hybri... menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.
Actinium: Iomab-B Phase 3 Trial Results Show Significant Survival Benefit In High-Risk AML Patients finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.